Focused Technology Research and Development (R01 Clinical Trial Not Allowed) | PAR 22 127

Opportunity Information: Apply for PAR 22 127

The NIH Focused Technology Research and Development opportunity (PAR-22-127) is an R01 grant mechanism designed for projects that concentrate specifically on building and advancing new biomedical research technologies, rather than using those technologies to answer particular biological or clinical questions. The central idea is to fund technically innovative work that can unlock future discovery by giving researchers better tools. Successful projects are expected to produce tangible, working prototypes such as instruments, experimental methods, synthetic or analytical approaches, or biological products. By the end of the award, the technology should be sufficiently characterized and validated to be ready for its first real use in the kinds of basic biomedical research settings that motivated its development. At the same time, the FOA draws a clear boundary: applying the technology to specific biomedical research questions is considered outside the scope of this program and should not be proposed, because that application work would not be funded under this announcement.

This program is positioned after proof-of-principle but before the technology is fully mature. Applicants are expected to have already demonstrated that the core concept can work, yet still face substantial, fundamental technical hurdles that must be solved to make the technology genuinely usable. Because of that expectation, applications should include preliminary data that support feasibility and justify that the remaining challenges are worth tackling. The opportunity also signals how applicants should think about scope, risk, and project design. If the project still carries considerable technical risk but has promising early feasibility results, NIH suggests it may fit better as a shorter, three-year R01 with a reduced budget to manage risk and limit investment until key hurdles are cleared. If feasibility studies are stronger and the plan is to deliver a fully functional prototype, a larger budget and longer project period may be appropriate, typically four years, with up to five years for early stage investigators. Proposals that mainly involve straightforward optimization, incremental hardening, or predictable extensions of established technologies are described as less competitive, implying that reviewers will be looking for real innovation and nontrivial technical problem-solving rather than routine engineering refinement.

As labeled in the title, clinical trials are not allowed under this FOA, reinforcing that the intended outcomes are research tools and enabling technologies rather than clinical testing. The funding instrument is a discretionary grant under the NIH R01 activity, tied to CFDA numbers 93.394, 93.859, and 93.866, and it sits within NIH program areas spanning education and health-related research support. The original closing date listed is 2025-05-07, and no award ceiling or expected number of awards is specified in the provided source fields, which typically means applicants should consult the full FOA and the relevant NIH Institute or Center guidance for budget norms and paylines.

Eligibility is broad and includes many common NIH applicant types: public and private institutions of higher education, state and local governments, special district governments, independent school districts, tribal governments (federally recognized) and other tribal organizations, public housing authorities/Indian housing authorities, nonprofit organizations with or without 501(c)(3) status, and for-profit organizations other than small businesses, as well as small businesses and other entities. The FOA explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions, along with faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. While foreign components are allowed as defined in the NIH Grants Policy Statement, non-U.S. institutions themselves are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible, which is an important distinction for teams planning international collaborations.

In practical terms, this opportunity is best suited for investigators who have a compelling technology concept with early evidence it can work, a clear set of hard technical milestones left to solve, and a development plan that ends with a validated prototype ready to be adopted by biomedical researchers. The strongest applications will typically make a convincing case for novelty and impact, define measurable performance goals and validation strategies (without drifting into hypothesis-driven biomedical discovery aims), and align the proposed timeline and budget with the maturity and risk level of the technology.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Focused Technology Research and Development (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394, 93.859, 93.866.
• This funding opportunity was created on 2022-03-21.
• Applicants must submit their applications by 2025-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 22 127

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: